Picture Kentro Design Corporate and Web Design for Start Ups 650x80px

Financing › Details

Alexion–AstraZeneca: investment, 202012– acquisition $39b with $13.4b in cash + $25.6b in ADSs Alexion shareholders will own 15% of combined firm

	Period	2020-12-12
	Money taker	AstraZeneca plc (LSE: AZN)
	Group	AstraZeneca (Group)
	Product	DRUGS, ORPHAN
	Product 2	pharmaceutical
	Source	AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]".

Record changed: 2021-01-27

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Alexion (Group)

[1] AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]"....
[2] Abingworth LLP. (7/9/18). "Press Release: Abingworth Raises $315m for ABV VII 12th Life Sciences Fund". London....
[3] Argen-X N.V. (Argenx). (4/9/18). "Press Release: Argenx Appoints Keith Woods as Chief Operating Officer". Breda & Ghent....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)